{"hands_on_practices": [{"introduction": "Understanding gene repression begins with the physical chemistry of molecular interactions. This exercise grounds the abstract concept of a repressor 'blocking' a promoter in the principles of thermodynamic equilibrium. By deriving the operator occupancy from mass action laws, you will uncover the quantitative relationship between repressor concentration and its effect, and critically evaluate the assumptions that bridge this idealized model to the complex environment of a living cell. [@problem_id:2860922]", "problem": "In the Escherichia coli tryptophan (trp) operon, repression is mediated by an active trp repressor dimer that binds a single operator site on deoxyribonucleic acid (DNA). Consider the minimal binding scheme in which the active repressor, denoted by concentration $[R]$, binds the operator site $O$ in a one-to-one reversible reaction $R + O \\rightleftharpoons RO$. Assume that on the timescale of transcription initiation, this binding reaction satisfies the law of mass action and is at thermodynamic equilibrium, and that the total operator concentration is $[O_{\\mathrm{tot}}] = [O] + [RO]$. The dissociation constant is defined by $K_d \\equiv \\frac{[R][O]}{[RO]}$. Using only these definitions and conservation, derive a closed-form expression for the fractional operator occupancy $\\theta \\equiv \\frac{[RO]}{[O_{\\mathrm{tot}}]}$ as a function of $[R]$ and $K_d$. \n\nThen, briefly identify the minimal physical assumptions required for this equilibrium expression to serve as a valid approximation to the in vivo occupancy of the trp operator when both repression and attenuation operate in the trp system. Your discussion should be rooted in first principles such as chemical equilibrium, separation of timescales, and conservation relations, and should make clear any concentration hierarchies or stoichiometric requirements needed in living cells, including the role of tryptophan as a corepressor that sets the pool of active $[R]$. \n\nProvide your final answer as the analytic expression for $\\theta$ in terms of $[R]$ and $K_d$ only. The quantity $\\theta$ is dimensionless; no rounding is required.", "solution": "This problem is subjected to validation before a solution is attempted.\n\n**Step 1: Extracted Givens**\n- System: Escherichia coli tryptophan (*trp*) operon.\n- Reaction: $R + O \\rightleftharpoons RO$, where $R$ is the active repressor and $O$ is the operator site.\n- Reaction is one-to-one, reversible, at thermodynamic equilibrium, and follows the law of mass action.\n- Conservation of operator sites: $[O_{\\mathrm{tot}}] = [O] + [RO]$.\n- Definition of dissociation constant: $K_d \\equiv \\frac{[R][O]}{[RO]}$.\n- Definition of fractional operator occupancy: $\\theta \\equiv \\frac{[RO]}{[O_{\\mathrm{tot}}]}$.\n- Objective 1: Derive a closed-form expression for $\\theta$ as a function of $[R]$ and $K_d$.\n- Objective 2: Briefly discuss the minimal physical assumptions for the validity of this model in vivo for the *trp* system, which includes both repression and attenuation.\n\n**Step 2: Validation of Problem Statement**\nThe problem is scientifically grounded, well-posed, and objective. It describes a standard equilibrium binding model, which is a fundamental concept in physical chemistry and molecular biology. All terms are clearly defined, and the premises are self-consistent and sufficient for the requested derivation. The second part of the question, concerning the model's limitations and underlying assumptions, requires a conceptual analysis based on established biophysical principles. The problem does not violate any criteria for validity.\n\n**Step 3: Verdict**\nThe problem is deemed valid. A full solution will be provided.\n\n**Derivation of Fractional Occupancy $\\theta$**\n\nThe objective is to derive an expression for the fractional operator occupancy, $\\theta$, defined as the ratio of the concentration of repressor-bound operator sites, $[RO]$, to the total concentration of operator sites, $[O_{\\mathrm{tot}}]$.\nThe definition is given as:\n$$\n\\theta \\equiv \\frac{[RO]}{[O_{\\mathrm{tot}}]}\n$$\nThe problem provides a conservation relation for the total operator concentration:\n$$\n[O_{\\mathrm{tot}}] = [O] + [RO]\n$$\nwhere $[O]$ is the concentration of free, unbound operator sites. Substituting this into the definition of $\\theta$ yields:\n$$\n\\theta = \\frac{[RO]}{[O] + [RO]}\n$$\nTo express $\\theta$ as a function of only $[R]$ and $K_d$, we must eliminate $[O]$ and $[RO]$ in favor of these variables. The dissociation constant, $K_d$, for the reversible reaction $R + O \\rightleftharpoons RO$ is given as:\n$$\nK_d = \\frac{[R][O]}{[RO]}\n$$\nFrom this definition, we can express the concentration of free operator, $[O]$, in terms of $[RO]$, $[R]$, and $K_d$:\n$$\n[O] = \\frac{K_d [RO]}{[R]}\n$$\nNow, substitute this expression for $[O]$ back into the equation for $\\theta$:\n$$\n\\theta = \\frac{[RO]}{\\left(\\frac{K_d [RO]}{[R]}\\right) + [RO]}\n$$\nThe term $[RO]$ is a common factor in the denominator. We can factor it out:\n$$\n\\theta = \\frac{[RO]}{[RO] \\left(\\frac{K_d}{[R]} + 1\\right)}\n$$\nAssuming a non-trivial case where binding occurs, such that $[RO] > 0$, we can cancel the $[RO]$ term from the numerator and denominator:\n$$\n\\theta = \\frac{1}{\\frac{K_d}{[R]} + 1}\n$$\nTo simplify this complex fraction, we multiply the numerator and the denominator by $[R]$:\n$$\n\\theta = \\frac{1 \\cdot [R]}{\\left(\\frac{K_d}{[R]} + 1\\right) \\cdot [R]} = \\frac{[R]}{K_d + [R]}\n$$\nThis is the final closed-form expression for the fractional operator occupancy $\\theta$ as a function of the active repressor concentration $[R]$ and the dissociation constant $K_d$. This functional form is known as the Langmuir isotherm or a Hill function with a Hill coefficient of $n=1$.\n\n**Discussion of Minimal Physical Assumptions for In Vivo Validity**\n\nFor this simple equilibrium model to be a valid approximation of the *in vivo* occupancy of the *trp* operator, several minimal physical assumptions must hold. These relate to timescales, concentration regimes, and the specific regulatory architecture of the *trp* system.\n\n$1$. **Separation of Timescales (Equilibrium Assumption):** The derivation assumes thermodynamic equilibrium. This holds only if the rates of repressor binding to and unbinding from the operator ($k_{\\text{on}}$ and $k_{\\text{off}}$, where $K_d = k_{\\text{off}}/k_{\\text{on}}$) are much faster than the rate of any other process that perturbs the system. In this context, the key competing process is transcription initiation. Therefore, the binding/unbinding dynamics must be rapid compared to the timescale of RNA polymerase (RNAP) binding and forming a transcriptionally-committed open complex. If RNAP initiates transcription faster than the repressor can dissociate and re-bind, the system is not in equilibrium, and a more complex steady-state model is required.\n\n$2$. **Buffered Concentration of Active Repressor ([R]):** The model treats $[R]$, the concentration of active repressor, as an independent parameter. In *E. coli*, the *trp* repressor is activated by binding its corepressor, tryptophan. $[R]$ is thus a function of the intracellular tryptophan concentration. The validity of the model requires that the equilibrium between inactive apo-repressor, tryptophan, and active repressor is also established very quickly relative to changes in gene expression. This ensures a well-defined pool of $[R]$ for any given metabolic state.\n\n$3$. **Concentration Hierarchy (Negligible Sequestration):** The derived expression for $\\theta$ assumes that $[R]$ represents the concentration of *free* active repressor, and that this concentration is not significantly depleted by binding to the operator. This is valid only if the total concentration of repressor molecules, $[R_{\\mathrm{tot}}]$, is much greater than the total concentration of its specific binding sites, $[O_{\\mathrm{tot}}]$. In *E. coli*, the cell contains only a few copies of the *trp* operon (low $[O_{\\mathrm{tot}}]$) but tens or hundreds of copies of the repressor protein. This condition, $[R_{\\mathrm{tot}}] \\gg [O_{\\mathrm{tot}}]$, is met, which prevents titration of the repressor and validates the use of a single value for $[R]$ in the binding equation.\n\n$4$. **Independence from Downstream Processes (Attenuation):** The *trp* operon features a second regulatory layer, attenuation, which occurs after transcription initiation. The model for operator occupancy $\\theta$ describes the probability that transcription is blocked at the promoter-operator region. Attenuation acts as an independent, subsequent checkpoint that can terminate transcription before the structural genes are transcribed. Because attenuation is a downstream event, its existence does not invalidate the equilibrium model for operator occupancy itself. The model correctly describes the fraction of time the operator is occupied by the repressor. To predict the overall output of the operon, one would need to multiply the probability of transcription initiation (which is related to $1-\\theta$) by the probability of not attenuating. The model for $\\theta$ remains a valid component of such a complete description.", "answer": "$$\n\\boxed{\\frac{[R]}{[R] + K_d}}\n$$", "id": "2860922"}, {"introduction": "The Trp operon's elegance lies in its dual-control system, where repression and attenuation act as sequential gates to fine-tune expression. This practice provides a quantitative framework for understanding how these two independent mechanisms combine to regulate transcriptional output. By calculating the fraction of polymerases that successfully navigate both checkpoints, you will gain a concrete appreciation for the multiplicative logic of multi-layered gene regulation. [@problem_id:2861072]", "problem": "In the Escherichia coli tryptophan (trp) operon, transcriptional output is controlled by both promoter repression via operator binding and by transcription attenuation in the leader region. Assume the following mechanistic base:\n- Under steady-state conditions with rapid equilibration, the operator occupancy $\\theta$ equals the fraction of time the promoter is occluded by repressor such that RNA polymerase cannot initiate transcription.\n- For an RNA polymerase molecule that successfully initiates, the attenuation control in the leader region induces transcription termination with probability $p_{\\text{term}}$ before the polymerase can enter the structural genes.\n- Assume statistical independence between promoter repression and attenuation events, a homogeneous flux of RNA polymerase arrivals at the promoter, and negligible additional regulatory interactions (for example, no roadblocks or pauses beyond attenuation that alter the effective probabilities).\n\nGiven operator occupancy $\\theta = 0.8$ and attenuation termination probability $p_{\\text{term}} = 0.6$, compute the expected fraction (dimensionless) of RNA polymerase molecules arriving at the trp promoter that ultimately reach the beginning of the first structural gene trpE. Express your answer as a decimal between $0$ and $1$. No rounding is required.", "solution": "The problem statement is first subjected to a rigorous validation procedure.\n\n**Step 1: Extract Givens**\n- The system is the *Escherichia coli* tryptophan ($trp$) operon.\n- Transcriptional output is controlled by two mechanisms: promoter repression and transcription attenuation.\n- Operator occupancy, denoted by $\\theta$, is the fraction of time the promoter is occluded by a repressor, preventing RNA polymerase initiation. The given value is $\\theta = 0.8$.\n- For an RNA polymerase that initiates transcription, the probability of premature termination in the leader region is $p_{\\text{term}}$. The given value is $p_{\\text{term}} = 0.6$.\n- The two control mechanisms, repression and attenuation, are statistically independent.\n- There is a homogeneous flux of RNA polymerase arrivals at the promoter.\n- No other regulatory interactions are to be considered.\n- The objective is to compute the expected fraction of RNA polymerase molecules arriving at the promoter that reach the beginning of the first structural gene, $trpE$.\n\n**Step 2: Validate Using Extracted Givens**\n- **Scientific Grounding**: The problem is scientifically grounded. The dual-control mechanism of the $trp$ operon involving a repressor (TrpR) and transcription attenuation is a canonical example in molecular genetics. The model presented, while a simplification, accurately reflects the fundamental logic of these two sequential, independent regulatory gates. The provided numerical values are plausible for a system under conditions of high tryptophan concentration. The problem does not violate any established scientific principles.\n- **Well-Posedness**: The problem is well-posed. It requests a uniquely defined quantity (a dimensionless fraction) and provides all necessary parameters ($\\theta$ and $p_{\\text{term}}$) and assumptions (statistical independence) to compute it.\n- **Objectivity**: The problem is stated in objective, quantitative language, free of ambiguity or subjective claims.\n\n**Step 3: Verdict and Action**\nThe problem is deemed valid as it is scientifically sound, well-posed, and objective. A solution will be derived.\n\n**Derivation of Solution**\nThe problem asks for the fraction of RNA polymerase (RNAP) molecules that arrive at the promoter and successfully proceed to transcribe the first structural gene, $trpE$. This process requires the successful navigation of two sequential, independent checkpoints: (1) promoter binding and transcription initiation, and (2) bypassing the attenuator sequence without premature termination.\n\nLet $F$ be the desired fraction. By the assumption of statistical independence, this fraction is the product of the probabilities of successfully passing each checkpoint.\n$$F = P(\\text{Initiation}) \\times P(\\text{No Attenuation} | \\text{Initiation})$$\n\nFirst, we consider the probability of transcription initiation, $P(\\text{Initiation})$. The problem states that the operator occupancy, $\\theta$, represents the fraction of time the promoter is occluded by the repressor. This is equivalent to the probability that a randomly arriving RNAP molecule finds the promoter inaccessible.\nThe value is given as $\\theta = 0.8$.\nTherefore, the probability that the promoter is *not* occluded and is available for RNAP to initiate transcription is:\n$$P(\\text{Initiation}) = 1 - \\theta$$\nSubstituting the given value:\n$$P(\\text{Initiation}) = 1 - 0.8 = 0.2$$\n\nSecond, we consider the probability of bypassing the attenuation mechanism, $P(\\text{No Attenuation} | \\text{Initiation})$. This event is conditional upon successful initiation. The problem provides the probability of transcription termination, $p_{\\text{term}}$, for any RNAP that has already initiated.\nThe value is given as $p_{\\text{term}} = 0.6$.\nThe event of interest is the complementary event: that transcription continues past the leader region. The probability for this is:\n$$P(\\text{No Attenuation} | \\text{Initiation}) = 1 - p_{\\text{term}}$$\nSubstituting the given value:\n$$P(\\text{No Attenuation} | \\text{Initiation}) = 1 - 0.6 = 0.4$$\n\nFinally, to find the overall fraction $F$ of arriving RNAP molecules that reach the $trpE$ gene, we multiply the probabilities of these two independent events:\n$$F = (1 - \\theta) \\times (1 - p_{\\text{term}})$$\nSubstituting the numerical values for each term:\n$$F = 0.2 \\times 0.4$$\n$$F = 0.08$$\n\nThis result, $F=0.08$, represents the expected fraction of RNAP molecules that arrive at the promoter, successfully initiate transcription, and successfully bypass the attenuation signal to begin transcribing the structural genes of the operon. This means that only $8\\%$ of the potential transcription events result in the production of a full-length polycistronic mRNA.", "answer": "$$\\boxed{0.08}$$", "id": "2861072"}, {"introduction": "A robust understanding of a biological system is demonstrated by the ability to predict the consequences of its perturbation. This practice challenges you to apply your integrated model of Trp operon control to analyze classic genetic mutants that disrupt the repression layer. By dissecting the functional differences between a repressor protein null mutant and an operator-constitutive mutation, you will sharpen your genetic reasoning and solidify your understanding of how the independent attenuation system continues to function. [@problem_id:2860991]", "problem": "In bacteria, transcription and translation are coupled, and multi-layer gene control can act at both transcription initiation and transcription elongation. Consider the Escherichia coli tryptophan (trp) operon, in which a tryptophan aporepressor protein (TrpR) binds operator DNA only when complexed with tryptophan, and an attenuation mechanism in the leader region uses a leader peptide containing consecutive tryptophan codons to bias formation of alternative RNA secondary structures that either allow RNA polymerase to continue or terminate transcription prematurely. Assume standard growth in which coupling between transcription and translation is intact.\n\nDefine the expected phenotypes of a trpR null mutant and an operator-constitutive mutation (Oc; an operator DNA change that abolishes TrpR binding) with respect to the repression layer and the attenuation layer. Then, at high intracellular tryptophan, distinguish their expression profiles of the structural genes relative to wild type. Choose the one option that is most consistent with first principles of transcriptional repression and attenuation under these conditions.\n\nA. Both trpR null and Oc mutants are constitutively derepressed at the initiation layer but retain a fully functional attenuation layer; therefore, at high tryptophan both mutants exhibit strong attenuation and low structural-gene expression that is nevertheless detectably higher than wild type because repression is absent.\n\nB. The trpR null mutant cannot carry out attenuation because TrpR is required to form the attenuator; therefore, at high tryptophan the trpR null exhibits very high structural-gene expression, whereas the Oc mutant behaves like wild type.\n\nC. The Oc mutant disrupts coupling between transcription and translation in the leader, abolishing attenuation; therefore, at high tryptophan the Oc mutant shows high structural-gene expression, while the trpR null remains strongly repressed by corepressor-bound TrpR.\n\nD. Because attenuation alone is sufficient to fully shut off transcription at high tryptophan, trpR null and Oc mutants are indistinguishable from wild type at high tryptophan, with no detectable structural-gene expression.\n\nE. The Oc mutation increases promoter strength and thus yields higher structural-gene expression than the trpR null at high tryptophan; both mutants also lack attenuation because the operator and attenuator act together as a single control element.", "solution": "The problem statement will first be validated for scientific and logical integrity.\n\n### Step 1: Extract Givens\n- **System**: The *Escherichia coli* tryptophan (*trp*) operon.\n- **Regulatory Mechanisms**:\n    $1$. **Repression**: A tryptophan aporepressor protein (TrpR) binds to an operator DNA sequence only when complexed with its corepressor, tryptophan. This binding blocks transcription initiation.\n    $2$. **Attenuation**: A leader region, transcribed before the structural genes, contains a coding sequence for a leader peptide with consecutive tryptophan codons. The rate of translation of this peptide influences the formation of alternative secondary structures in the nascent RNA. One structure allows transcription to proceed (anti-terminator), while the other causes premature termination (terminator).\n- **Cellular Context**: Transcription and translation are coupled, as is standard in bacteria.\n- **Mutants for Analysis**:\n    $1$. A `trpR⁻` null mutant, which produces no functional TrpR protein.\n    $2$. An operator-constitutive mutant (`Oᶜ`), where the operator DNA sequence is altered so that the TrpR-tryptophan complex cannot bind.\n- **Condition**: High intracellular concentration of tryptophan.\n- **Objective**: Define the phenotypes of the `trpR⁻` and `Oᶜ` mutants with respect to both regulatory layers and compare their structural gene expression to wild type under high tryptophan conditions.\n\n### Step 2: Validate Using Extracted Givens\n- **Scientific Grounding**: The description of the *trp* operon's dual-control system—negative repressible control at the operator and attenuation in the leader region—is a cornerstone of prokaryotic gene regulation. The roles of TrpR, tryptophan as a corepressor, the operator, the leader peptide with its Trp codons, and the formation of the 2-3 anti-terminator versus the 3-4 terminator stem-loops are all well-established, factually correct principles from molecular genetics. The problem is scientifically sound.\n- **Well-Posedness**: The problem asks for the phenotypic consequences of specific, well-defined genetic mutations (`trpR⁻` and `Oᶜ`) under a specified condition (high tryptophan). The question is structured to have a unique, logical answer derivable from the provided principles.\n- **Objectivity**: The problem is stated in precise, unbiased scientific language, free of subjective claims or ambiguity. The mutations and mechanisms are clearly defined.\n\n### Step 3: Verdict and Action\nThe problem statement is scientifically valid, well-posed, and objective. It contains no contradictions or missing information. A rigorous solution can be derived from first principles.\n\n### Derivation of Solution\nThe *trp* operon's expression is controlled by two distinct, layered mechanisms: repression at the level of transcription initiation and attenuation at the level of transcription elongation.\n\n$1$. **Wild-Type (WT) Regulation**:\n- At **high tryptophan concentration**, two events occur to shut down the operon:\n    - **Repression**: Tryptophan binds to the TrpR aporepressor, activating it. The active TrpR-tryptophan repressor complex binds to the operator sequence (O). This physically blocks RNA polymerase from initiating transcription. This mechanism alone reduces expression by a factor of approximately $70$.\n    - **Attenuation**: For the few transcripts that escape repression (leaky transcription), the attenuation mechanism provides a second layer of control. With high tryptophan levels, the concentration of charged ${\\text{tRNA}}^{\\text{Trp}}$ is also high. The ribosome translating the leader peptide sequence does not stall at the two tandem Trp codons. It proceeds rapidly, covering region $2$ of the leader transcript. This allows the thermodynamically favorable 3-4 terminator stem-loop to form. This structure signals RNA polymerase to terminate transcription before reaching the structural genes. This mechanism reduces expression by an additional factor of approximately $10$.\n- The combined effect in a WT cell at high tryptophan is a strong shutdown of expression, reduced by a factor of $\\approx 70 \\times 10 = 700$ compared to the fully derepressed state.\n\n$2$. **Analysis of the trpR⁻ Null Mutant**:\n- This mutant produces no TrpR protein. Consequently, the repression mechanism is non-functional. The operator site is never occupied, regardless of the intracellular tryptophan concentration. Transcription initiation is constitutive, meaning it is always \"on\" from the perspective of the repression system.\n- At **high tryptophan concentration**, although repression is absent, the attenuation mechanism is still fully intact. The components of attenuation (the leader transcript, ribosome, tRNA levels) are independent of the TrpR protein. High tryptophan leads to a high concentration of charged ${\\text{tRNA}}^{\\text{Trp}}$, rapid ribosome transit over the Trp codons, formation of the 3-4 terminator stem-loop, and premature termination of transcription.\n- **Phenotype**: The operon is derepressed at the initiation level but attenuated at the elongation level. Expression of structural genes will be low due to attenuation, but it will be approximately 70-fold higher than the fully repressed and attenuated WT cell, because the major repressive effect is absent.\n\n$3$. **Analysis of the Operator-Constitutive (Oᶜ) Mutant**:\n- In this mutant, the operator DNA sequence is changed such that the active TrpR-tryptophan complex cannot bind to it. The functional consequence for the repression system is identical to that of the `trpR⁻` mutant: repression is impossible. Transcription initiation is constitutive.\n- At **high tryptophan concentration**, just as in the `trpR⁻` mutant, the attenuation mechanism remains functional and is triggered by the high levels of tryptophan. The 3-4 terminator hairpin forms, causing transcription to terminate prematurely.\n- **Phenotype**: The phenotype of the Oᶜ mutant is identical to the trpR⁻ mutant. It is constitutively derepressed at initiation but subject to attenuation. Its expression level at high tryptophan will be low, but detectably and significantly higher than WT.\n\n### Option-by-Option Analysis\n\n**A. Both trpR null and Oc mutants are constitutively derepressed at the initiation layer but retain a fully functional attenuation layer; therefore, at high tryptophan both mutants exhibit strong attenuation and low structural-gene expression that is nevertheless detectably higher than wild type because repression is absent.**\n- This statement accurately describes the consequences of both mutations. Both `trpR⁻` and `Oᶜ` abolish repression, making initiation constitutive. The attenuation mechanism is separate and remains functional. At high tryptophan, attenuation is active, leading to low expression. Critically, this \"low\" expression is higher than the \"very low\" basal expression of WT cells, which are subject to both repression and attenuation. The difference, a factor of $\\approx 70$, is readily detectable.\n- **Verdict: Correct.**\n\n**B. The trpR null mutant cannot carry out attenuation because TrpR is required to form the attenuator; therefore, at high tryptophan the trpR null exhibits very high structural-gene expression, whereas the Oc mutant behaves like wild type.**\n- The first premise, \"TrpR is required to form the attenuator\", is fundamentally incorrect. The attenuator is an RNA structure whose formation is governed by ribosome movement, not by the TrpR protein. The rest of the statement consists of incorrect conclusions based on this false premise. For example, an Oᶜ mutant does not behave like wild type; it is non-repressible.\n- **Verdict: Incorrect.**\n\n**C. The Oc mutant disrupts coupling between transcription and translation in the leader, abolishing attenuation; therefore, at high tryptophan the Oc mutant shows high structural-gene expression, while the trpR null remains strongly repressed by corepressor-bound TrpR.**\n- This statement contains multiple errors. An Oᶜ mutation is in a non-transcribed DNA regulatory element and does not affect the process of transcription-translation coupling in the downstream leader transcript. Also, a trpR⁻ null mutant cannot be repressed because it lacks the repressor protein.\n- **Verdict: Incorrect.**\n\n**D. Because attenuation alone is sufficient to fully shut off transcription at high tryptophan, trpR null and Oc mutants are indistinguishable from wild type at high tryptophan, with no detectable structural-gene expression.**\n- This statement misrepresents the quantitative nature of the regulation. Attenuation is not sufficient to \"fully shut off\" transcription; it reduces it by only about a factor of $10$. Repression is the more potent mechanism. Consequently, the mutants (lacking repression) have an expression level $\\approx 70$-fold higher than WT, a very distinguishable difference. Expression is detectable in all cases, even the fully repressed WT state (basal expression).\n- **Verdict: Incorrect.**\n\n**E. The Oc mutation increases promoter strength and thus yields higher structural-gene expression than the trpR null at high tryptophan; both mutants also lack attenuation because the operator and attenuator act together as a single control element.**\n- This statement is flawed throughout. An Oᶜ mutation affects a repressor binding site, not the promoter; it does not alter promoter strength. The Oᶜ and trpR⁻ mutations have identical functional consequences for the operon's expression, so one would not yield higher expression than the other. Finally, the operator and attenuator are distinct regulatory elements mediating separate mechanisms; a mutation in one does not abolish the function of the other.\n- **Verdict: Incorrect.**", "answer": "$$\\boxed{A}$$", "id": "2860991"}]}